Sample size determination for the current strategy in oncology Phase 3 trials that tests progression-free survival and overall survival in a two-stage design framework.
about
Sample size determination for the current strategy in oncology Phase 3 trials that tests progression-free survival and overall survival in a two-stage design framework.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Sample size determination for ...... a two-stage design framework.
@en
Sample size determination for ...... a two-stage design framework.
@nl
type
label
Sample size determination for ...... a two-stage design framework.
@en
Sample size determination for ...... a two-stage design framework.
@nl
prefLabel
Sample size determination for ...... a two-stage design framework.
@en
Sample size determination for ...... a two-stage design framework.
@nl
P2860
P1476
Sample size determination for ...... a two-stage design framework.
@en
P2093
Akihiro Hirakawa
Chikuma Hamada
P2860
P304
P356
10.1080/10543406.2017.1372775
P50
P577
2017-09-08T00:00:00Z